|
All patients from 2004 to 2012
|
Any ET
|
ECMO
|
RRT
|
|---|
|
N = 49,153 PSS cases
|
|---|
|
Use in PSS, N (%)
|
4795 (9.8 %)
|
1858 (3.8 %)
|
3437 (7.0 %)
|
|
Gender, N (%)
|
|
Male
|
2452 (51.2 %)
|
978 (52.7 %)
|
1728 (50.3 %)
|
|
Female
|
2342 (48.8 %)
|
879 (47.3 %)
|
1709 (49.7 %)
|
|
Age group at admission, N (%)
|
|
<1 year
|
1198 (25.0 %)
|
830 (44.7 %)
|
537 (15.6 %)
|
|
1–4 years
|
1102 (23.0 %)
|
421 (22.7 %)
|
783 (22.8 %)
|
|
5–9 years
|
657 (13.7 %)
|
192 (10.3 %)
|
531 (15.5 %)
|
|
10–18 years
|
1838 (38.3 %)
|
415 (22.3 %)
|
1586 (46.1 %)
|
|
Total hospitalization, days
|
|
Median (25 %–75 %)
|
34 (17–64)
|
35 (16–67)
|
34 (17–62)
|
|
ICU, days
|
|
Median (25 %–75 %)
|
19 (8–38)
|
25 (12–48)
|
17 (7–34)
|
|
Co-morbidities, N (%)
|
|
Any condition
|
3745 (78.1 %)
|
1,456 (78.4 %)
|
2645 (77.0 %)
|
|
Neurologic
|
580 (12.1 %)
|
198 (10.7 %)
|
424 (12.3 %)
|
|
Cardiovascular
|
1734 (36.2 %)
|
1119 (60.2 %)
|
849 (24.7 %)
|
|
Respiratory
|
263 (5.5 %)
|
156 (8.4 %)
|
141 (4.1 %)
|
|
Renal
|
767 (16.0 %)
|
92 (5.0 %)
|
708 (20.6 %)
|
|
Gastroenterology
|
304 (6.3 %)
|
64 (3.4 %)
|
258 (7.5 %)
|
|
Hematology/Immunology
|
452 (9.4 %)
|
139 (7.5 %)
|
347 (10.1 %)
|
|
Metabolic disorder
|
976 (20.4 %)
|
207 (11.1 %)
|
844 (24.6 %)
|
|
Malignancy
|
855 (17.8 %)
|
133 (7.1 %)
|
773 (22.5 %)
|
|
Other
|
417 (8.7 %)
|
216 (11.6 %)
|
234 (6.8 %)
|
|
Acute organ dysfunction
|
|
Number of systems affected, N (%)
|
|
1
|
969 (20.2 %)
|
286 (15.4 %)
|
728 (21.2 %)
|
|
2
|
1779 (37.1 %)
|
831 (44.7 %)
|
1133 (33.0 %)
|
|
3
|
1187 (24.8 %)
|
462 (24.9 %)
|
878 (25.6 %)
|
|
4
|
611 (12.7 %)
|
205 (11.0 %)
|
494 (14.4 %)
|
|
5+
|
249 (5.2 %)
|
74 (4.0 %)
|
204 (5.9 %)
|
-
PSS pediatric severe sepsis, ET extracorporeal therapy, ECMO extracorporeal membrane oxygenation, RRT Renal replacement therapy
